vs

Side-by-side financial comparison of Invesco (IVZ) and J.M. Smucker Company (The) (SJM). Click either name above to swap in a different company.

J.M. Smucker Company (The) is the larger business by last-quarter revenue ($2.3B vs $1.7B, roughly 1.4× Invesco). J.M. Smucker Company (The) runs the higher net margin — 10.4% vs -58.9%, a 69.2% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs 2.6%). Invesco produced more free cash flow last quarter ($432.2M vs $280.2M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 2.2%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

The J.M. Smucker Company, also known as Smucker's, is an American manufacturer of food and beverage products. Headquartered in Orrville, Ohio, the company was founded in 1897 as a maker of apple butter. J.M. Smucker currently has three major business units: consumer foods, pet foods, and coffee. Its flagship brand, Smucker's, produces fruit preserves, peanut butter, syrups, frozen crustless sandwiches, and ice cream toppings.

IVZ vs SJM — Head-to-Head

Bigger by revenue
SJM
SJM
1.4× larger
SJM
$2.3B
$1.7B
IVZ
Growing faster (revenue YoY)
IVZ
IVZ
+3.6% gap
IVZ
6.2%
2.6%
SJM
Higher net margin
SJM
SJM
69.2% more per $
SJM
10.4%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$152.0M more FCF
IVZ
$432.2M
$280.2M
SJM
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
2.2%
SJM

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IVZ
IVZ
SJM
SJM
Revenue
$1.7B
$2.3B
Net Profit
$-995.9M
$241.3M
Gross Margin
37.3%
Operating Margin
-86.2%
18.0%
Net Margin
-58.9%
10.4%
Revenue YoY
6.2%
2.6%
Net Profit YoY
-575.8%
1084.9%
EPS (diluted)
$-2.61
$2.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
SJM
SJM
Q4 25
$1.7B
$2.3B
Q3 25
$1.6B
$2.1B
Q2 25
$1.5B
$2.1B
Q1 25
$1.5B
$2.2B
Q4 24
$1.6B
$2.3B
Q3 24
$1.5B
$2.1B
Q2 24
$1.5B
$2.2B
Q1 24
$1.5B
$2.2B
Net Profit
IVZ
IVZ
SJM
SJM
Q4 25
$-995.9M
$241.3M
Q3 25
$356.4M
$-43.9M
Q2 25
$197.4M
$-729.0M
Q1 25
$171.1M
$-662.3M
Q4 24
$209.3M
$-24.5M
Q3 24
$55.0M
$185.0M
Q2 24
$132.2M
$245.1M
Q1 24
$141.5M
$120.4M
Gross Margin
IVZ
IVZ
SJM
SJM
Q4 25
37.3%
Q3 25
22.5%
Q2 25
38.4%
Q1 25
40.2%
Q4 24
39.0%
Q3 24
37.5%
Q2 24
41.4%
Q1 24
36.9%
Operating Margin
IVZ
IVZ
SJM
SJM
Q4 25
-86.2%
18.0%
Q3 25
16.5%
2.2%
Q2 25
14.1%
-27.9%
Q1 25
18.1%
-27.2%
Q4 24
19.6%
7.5%
Q3 24
6.6%
16.4%
Q2 24
13.9%
18.4%
Q1 24
14.4%
13.3%
Net Margin
IVZ
IVZ
SJM
SJM
Q4 25
-58.9%
10.4%
Q3 25
21.7%
-2.1%
Q2 25
13.0%
-34.0%
Q1 25
11.2%
-30.3%
Q4 24
13.1%
-1.1%
Q3 24
3.6%
8.7%
Q2 24
8.9%
11.1%
Q1 24
9.6%
5.4%
EPS (diluted)
IVZ
IVZ
SJM
SJM
Q4 25
$-2.61
$2.26
Q3 25
$0.66
$-0.41
Q2 25
$-0.03
$-6.86
Q1 25
$0.38
$-6.22
Q4 24
$0.46
$-0.23
Q3 24
$0.12
$1.74
Q2 24
$0.29
$2.31
Q1 24
$0.31
$1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
SJM
SJM
Cash + ST InvestmentsLiquidity on hand
$1.0B
Total DebtLower is stronger
$1.8B
$7.0B
Stockholders' EquityBook value
$12.2B
$6.1B
Total Assets
$27.1B
$17.6B
Debt / EquityLower = less leverage
0.15×
1.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
SJM
SJM
Q4 25
$1.0B
Q3 25
$973.1M
Q2 25
$922.7M
Q1 25
$821.7M
Q4 24
$986.5M
Q3 24
$1.0B
Q2 24
$878.5M
Q1 24
$895.7M
Total Debt
IVZ
IVZ
SJM
SJM
Q4 25
$1.8B
$7.0B
Q3 25
$1.6B
$7.0B
Q2 25
$1.9B
$7.0B
Q1 25
$964.8M
$7.4B
Q4 24
$890.6M
$7.8B
Q3 24
$890.3M
$7.8B
Q2 24
$890.1M
$7.8B
Q1 24
$1.3B
$8.1B
Stockholders' Equity
IVZ
IVZ
SJM
SJM
Q4 25
$12.2B
$6.1B
Q3 25
$14.0B
$5.9B
Q2 25
$13.9B
$6.1B
Q1 25
$14.7B
$6.9B
Q4 24
$14.6B
$7.6B
Q3 24
$14.8B
$7.8B
Q2 24
$14.6B
$7.7B
Q1 24
$14.6B
$7.6B
Total Assets
IVZ
IVZ
SJM
SJM
Q4 25
$27.1B
$17.6B
Q3 25
$28.4B
$17.7B
Q2 25
$28.5B
$17.6B
Q1 25
$28.1B
$18.4B
Q4 24
$27.0B
$20.0B
Q3 24
$27.5B
$20.3B
Q2 24
$27.2B
$20.3B
Q1 24
$28.1B
$20.2B
Debt / Equity
IVZ
IVZ
SJM
SJM
Q4 25
0.15×
1.16×
Q3 25
0.12×
1.19×
Q2 25
0.14×
1.16×
Q1 25
0.07×
1.07×
Q4 24
0.06×
1.02×
Q3 24
0.06×
1.00×
Q2 24
0.06×
1.01×
Q1 24
0.09×
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
SJM
SJM
Operating Cash FlowLast quarter
$455.8M
$346.5M
Free Cash FlowOCF − Capex
$432.2M
$280.2M
FCF MarginFCF / Revenue
25.5%
12.0%
Capex IntensityCapex / Revenue
1.4%
2.8%
Cash ConversionOCF / Net Profit
1.44×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$635.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
SJM
SJM
Q4 25
$455.8M
$346.5M
Q3 25
$606.2M
$-10.6M
Q2 25
$547.9M
$393.9M
Q1 25
$-84.6M
$239.4M
Q4 24
$316.9M
$404.2M
Q3 24
$438.4M
$172.9M
Q2 24
$489.1M
$428.1M
Q1 24
$-54.4M
$406.5M
Free Cash Flow
IVZ
IVZ
SJM
SJM
Q4 25
$432.2M
$280.2M
Q3 25
$586.4M
$-94.9M
Q2 25
$530.4M
$298.9M
Q1 25
$-108.0M
$151.3M
Q4 24
$309.9M
$317.2M
Q3 24
$410.0M
$49.2M
Q2 24
$462.4M
$297.5M
Q1 24
$-75.4M
$249.6M
FCF Margin
IVZ
IVZ
SJM
SJM
Q4 25
25.5%
12.0%
Q3 25
35.7%
-4.5%
Q2 25
35.0%
13.9%
Q1 25
-7.1%
6.9%
Q4 24
19.5%
14.0%
Q3 24
27.1%
2.3%
Q2 24
31.2%
13.5%
Q1 24
-5.1%
11.2%
Capex Intensity
IVZ
IVZ
SJM
SJM
Q4 25
1.4%
2.8%
Q3 25
1.2%
4.0%
Q2 25
1.2%
4.4%
Q1 25
1.5%
4.0%
Q4 24
0.4%
3.8%
Q3 24
1.9%
5.8%
Q2 24
1.8%
5.9%
Q1 24
1.4%
7.0%
Cash Conversion
IVZ
IVZ
SJM
SJM
Q4 25
1.44×
Q3 25
1.70×
Q2 25
2.78×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
7.97×
0.93×
Q2 24
3.70×
1.75×
Q1 24
-0.38×
3.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

SJM
SJM

U.S.Retail Frozen Handheld And Spreads$461.1M20%
U.S.Retail Pet Foods$413.2M18%
Handheld Frozen Sandwiches$262.9M11%
Sweet Baked Snacks$256.1M11%
Pet Snacks$232.0M10%
Cat Food$197.2M8%
Peanut Butter$187.1M8%
CA$94.5M4%
Fruit Spreads$92.2M4%
Other$50.5M2%
Portion Control$50.1M2%
All Other International$33.2M1%

Related Comparisons